Skip to content

TAKTAKEDA PHARMACEUTIC-SP ADR

CUSIP 874060205 · depositary receipt

2 tracked investors held TAKEDA PHARMACEUTIC-SP ADR (TAK) at the end of Q3 2026, worth $2.4M in total. The largest holder was Ken Fisher, with 0.0% of its portfolio. Ken Fisher opened a new position this quarter.

Holders · Q3 2026
2
New holders
1
Value held
$2.4M
Quarter-end price (est.)
$18.19

Investors holding TAK · Q3 2026

InvestorWeightSharesValueChange
Ken Fisher
Fisher Asset Management, LLC
0.00%86,978$1.6MNEW
Richard Pzena
Pzena Investment Management LLC
0.00%45,310$824.2KADD+19.8%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026210$2.4M$18.19
Q2 2026100$606.3K$16.03
Q1 2026100$525.2K$18.52
Q4 2025100$321.6K$15.59
Q4 2019001$0—
Q3 2019100$162.3M$17.20
Q2 2019100$167.1M$17.70
Q1 2019110$217.3M$20.37